Bacil Pharma Ltd.
BSE: 524516 | Sector: Health care |
NSE: N.A. | ISIN Code: INE711D01018 |
BSE 00:00 | 24 May | 4.63 |
-0.22 (-4.54%) |
OPEN
5.00 |
HIGH
5.00 |
LOW
4.63 |
NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
OPEN | 5.00 |
PREVIOUS CLOSE | 4.85 |
VOLUME | 300 |
52-Week high | 9.55 |
52-Week low | 3.67 |
P/E | |
Mkt Cap.(Rs cr) | 3 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Bacil Pharma Ltd. (BACILPHARMA) - Company Information
Incorporated as a private limited company in Maharashtra in May '87 Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol norfloxacin pefloxacin and ciprofloxacin. The comapany entered into a marketing arrangement with a distributor Kam Han Industries Hong K...> More
COMPANY INFORMATION | |||||||
Independent Director : | Shirish Shetye | ||||||
Director : | Prakash Shah | ||||||
Independent Director : | Lalit Jain | ||||||
Director : | Sneha Shah | ||||||
Company Secretary : | Vaishali Vaghasiya | ||||||
AUDITOR : | Laxmikant Kabra & Co LLP | ||||||
IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
HOUSE NAME : | Indian Private | ||||||
Registered office | |||||||
71 Laxmi Building, Sir P M Road Fort,Mumbai,Maharashtra-400001 | |||||||
Ph : 91-022-22618452 | |||||||
WEBSITE : http://www.bacilpharma.com | |||||||
E-mail : bacilpha@yahoo.com |
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices